Rallybio Corp
For the period ended Dec 31, 2023. Filed Mar 12, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 12, 2024
RLYB$15.76+0.6%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Changes in Stockholders' Equity
| COMMON · ADDITIONALPAID-INCAPITAL · ACCUMULATEDDEFICIT · ACCUMULATED OTHERCOMPREHENSIVEGAIN (LOSS) · STOCKHOLDERS'EQUITY | ||||||
|---|---|---|---|---|---|---|
| (in thousands, except share amounts) · SHARES · AMOUNT | ||||||
| December 31, 2021 | 32,129,970 | $3 | $269,626 | $(94,027) | $— | $175,602 |
| Issuance of common stock and pre-funded warrants upon completion of the follow-on offering, net of underwriting discounts and commissions and offering costs of $3,976 | 5,803,655 | 1 | 50,845 | — | — | 50,846 |
| Issuance of common stock from the stock purchase plan | 38,845 | — | 217 | — | — | 217 |
| Issuance of common stock from the stock award plan | 2,000 | — | — | — | — | — |
| Issuance of common stock from exercise of stock options | 2,014 | — | 21 | — | — | 21 |
| Forfeiture of restricted common stock | (139,115) | — | — | — | — | — |
| Share-based compensation expense | — | — | 9,499 | — | — | 9,499 |
| Net loss | — | — | — | (66,654) | — | (66,654) |
| Other comprehensive gain (loss) | — | — | — | — | (214) | (214) |
| Balance, December 31, 2022 | 37,837,369 | $4 | $330,208 | $(160,681) | $(214) | $169,317 |
| Issuance of common stock from the stock purchase plan | 79,283 | $— | $282 | $— | $— | $282 |
| Issuance of common stock from the stock award plan | 11,219 | — | — | — | — | — |
| Forfeiture of restricted common stock | (98,306) | — | — | — | — | — |
| Share-based compensation expense | — | — | 10,920 | — | — | 10,920 |
| Net loss | — | — | — | (74,564) | — | (74,564) |
| Other comprehensive gain (loss) | — | — | — | — | 229 | 229 |
| Balance, December 31, 2023 | 37,829,565 | $4 | $341,410 | $(235,245) | $15 | $106,184 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.